Vitamin D Supplementation and Fracture Incidence in
Elderly Persons
A Randomized. Placebo-Controlled Clinical Trial
Paul Lips, MD; Wilco C. Graafmans, MS; Marcel E. Ooms, MD; P. Dick Bezemer, PhD;
and Lex M. Bouter, PhD
Objective: To determine whether vitamin D supplemen V itamin D deficiency is common in elderly per
tation decreases the incidence of hip fractures and other sons, especially those with hip fracture (1, 2).
peripheral bone fractures.
It is caused by low exposure to sunshine, decreased
Design: Prospective, double-blind trial. synthesis of vitamin D in the aging skin, and a diet
3
Setting: Community setting (Amsterdam and surround low in vitamin D (3, 4). The mean vitamin D intake
ing area). in elderly persons in the Netherlands is about 100
IU/d, half that of elderly persons in the United
Patients: 2578 persons (1916 women, 662 men) 70 years
States (5). Most of this vitamin D comes from mar
of age and older (mean age ± SD 80 ± 6 years) living
f
independently, in apartments for elderly persons, or in garine, which is the only vitamin D-supplemented
homes for elderly persons. food in the Netherlands (3 IU/g). In vitamin D
deficiency, the low serum concentration of 25-hy-
Intervention: Participants were randomly assigned to
receive either vitamin D , 400 IU in one tablet daily, or droxyvitamin D [25(OH)D] leads to a low 1,25-dihy-
3
placebo for a maximum of 3.5 years. droxyvitamin D [l,25(OH)2D] concentration and then
to a higher serum parathyroid hormone concentra
Measurements: Dietary calcium intake and serum 25-
hydroxyvitamin D [25(OH)D] were estimated in a subset of tion, especially in the winter (6-10). Histologically,
participants. During follow-up, attention was concen the increased parathyroid activity is associated with
trated on hip fractures and other peripheral fractures. The high bone turnover, leading to cortical bone loss
maximal follow-up period was 4 years. The results were and low density bone (5, 11), which may lead to hip
evaluated by survival analysis. fracture.
Results: Mean dietary calcium intake from dairy prod We previously studied the effects of vitamin D
ucts was 868 mg/d. Mean serum 25(OH)D concentration in supplementation in residents of a home for the
the third year of the study was 23 nmol/L in the placebo elderly and residents of a nursing home (10). Vita
group and 60 nmol/L in the vitamin D group. Median
min D , 400 IU/d, led to an adequate increase of
follow-up was 3.5 years, and total follow-up was 8450 3
the serum 25(OH)D concentration, to a small but
patient-years. During follow-up, 306 persons in the pla
significant increase of the serum l,25(OH)2D con
cebo group and 282 persons in the vitamin D group died
centration, and to a decrease of the serum concen
(P = 0.20). Hip fractures occurred in 48 persons in the
placebo group and 58 persons in the vitamin D group (P = tration of intact parathyroid hormone. It was re
0.39, intention-to-treat analysis). Other peripheral frac cently observed (12, 13) that bone mineral density
tures occurred in 74 persons in the placebo group and 77 at the hip is positively related to serum 25(OH)D
persons in the vitamin D group (P = 0.86). concentration in postmenopausal and elderly women.
Conclusion: Our results do not show a decrease in the Therefore, it might be expected that vitamin D sup
incidence of hip fractures and other peripheral fractures in plementation would increase bone mineral density
Dutch elderly persons after vitamin D supplementation. in elderly persons deficient in vitamin D. In line
with this expectation, it was shown that vitamin D
supplementation prevented bone loss from the spine
during the winter in postmenopausal women (14).
These results suggest that vitamin D supplemen
tation may reduce the incidence of hip fractures,
because bone strength shows a strong correlation
with bone mineral density (15). However, increasing
bone mineral density through a therapeutic inter
vention does not necessarily lead to increased bone
strength, as has been shown with sodium fluoride
Ann Intern Med. 1996;124:400-406. (16). Bone structure and bone quality are also de
terminants of bone strength (17), and falls are a risk
From Vrije Universiteit, Amsterdam, the Netherlands. For cur
rent author addresses, see end of text. factor for hip fractures (18). Therefore, hip fracture
400 © 1996 American College of Physicians
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
should be the outcome criterion in studies on the replaced every 6 months with a full container. All
effect of vitamin D supplementation. Intervention participants were also advised in writing to consume
studies on the prevention of osteoporotic fractures at least three servings of dairy products per day (for
necessitate large numbers of patients, because the example, 1 glass of milk, 1 cup of yogurt, and 1 slice
outcome has an annual incidence of 0.5% to 4% in of cheese) to ensure a calcium intake of at least 800
the elderly population (19). We report the results of to 1000 mg/d.
a large-scale, prospective study on the effect of vi The study was started in August 1988. The last
tamin D supplementation on the incidence of hip participant was enrolled in December 1990, and all
and other osteoporotic fractures. participants had stopped using study medication by
December 1993. The follow-up period had been
planned to last no more than 3 years, but because
the number of hip fractures during the study was
Methods
lower than expected, a 6-month extension was
planned. The study participants thus received med
Participants
ication for 3 to 3.5 years; those who received it for
The study included 2578 persons (1916 women and
3.5 years were those who consented to the 6-month
662 men) 70 years of age and older (mean age ±
extension. Total follow-up was to a maximum of 4
SD, 80 ± 6 years; range, 70 to 97 years). Partici
years.
pants were recruited from general practitioners,
Data collected at baseline included an outdoor
from apartment houses for elderly persons, and
activity score (1 = going outdoors less than once a
from homes for elderly persons in Amsterdam and
week; 2 = going outdoors 1 or 2 times per week;
its vicinity. Persons recruited from practitioners
and 3 = going outdoors 3 times per week or more)
were living independently; those recruited from
and a score for sunshine exposure (when outside:
apartment houses and homes were receiving some
1 = in the shade as much as possible; 2 = some
care, but less than they would have received in a
times in sunshine; 3 = much exposure to sunshine).
nursing home. Participants had to be reasonably
These scores show a positive relation with serum
healthy and able to give informed consent. Persons
25(OH)D concentration (3). Mobility was estimated
with a history of hip fracture or total hip arthro
by a walking score that ranged from 1 (unable to
plasty, known hypercalcemia, sarcoidosis, or recent
walk) to 5 (walks independently a fair distance on
urolithiasis (< 5 years earlier) were excluded. Pa
any surface) (20). The dietary calcium intake from
tients who had diseases or who used medications
dairy products was estimated in a subset of 348
that influence bone metabolism (such as thyroid
women by using a questionnaire, as described pre
disease or glucocorticoid medication) were not ex
viously (21).
cluded. The spontaneous use of vitamin D supple
The participants were evaluated annually with a
ments and multivitamins was discouraged, but the
questionnaire on hip fractures, other peripheral
prescription practices of the general practitioners
fractures, outdoor score, sunshine exposure score,
were not altered. All vitamin use was carefully doc
use of vitamin supplements, and walking score.
umented. The study was approved by the Ethical
Each general practitioner or caretaker was asked to
Review Board of the Vrije Universiteit Hospital,
immediately report change of address, hip fracture,
and all participants gave informed consent.
or death. Hip fracture and death were verified by
the general practitioner. All participants were fol
Study Design lowed for the maximal period of 4 years if possible,
After checking the inclusion and exclusion crite even if they had stopped using the trial medication,
ria and obtaining informed consent, the participants had sustained a fracture, or had moved to another
were randomly assigned to receive either active city. To investigate possible selection bias, 267 po
treatment with vitamin D or placebo. The study tential participants in a home for the elderly and its
3
was double-blind, and randomization was done in adjunct apartments (all residents of the institution)
blocks of 10 per general practice, apartment house, were studied for baseline characteristics, including
or home. Randomization lists were made using a age, sex, sunshine exposure score, outdoor score,
computerized random-number generator. Lists in walking score, and reasons for nonparticipation.
sealed envelopes were sent to the hospital pharmacy Compliance was checked when the tablet con
for assignment. Each participant took either one tainers were replaced (every 6 months), by question
tablet per day that contained vitamin D , 400 IU, or naire (every year), and by measurement of the serum
3
one placebo tablet per day that was identical in 25(OH)D concentration. Serum 25(OH)D concentra
appearance and taste to the vitamin tablet. After tion was measured at baseline and after 1 year in
enrollment, the participants received the first con 270 persons who participated in a substudy investi
tainer of tablets (210 tablets). The container was gating the effect of vitamin D supplementation on
15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4 401
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
bone mineral density and bone turnover variables. (23). Hip fractures are presented using the Kaplan-
This substudy included a nonrandom sample of par Meier method. All participants were kept in the
ticipants from several apartment houses and homes study as long as possible. The data were analyzed in
for the elderly and is described in detail elsewhere two ways. The intention-to-treat analysis included
(21). In the same substudy, dietary calcium intake all randomly assigned participants for either the
from dairy products was assessed. Serum 25(OH)D total follow-up period or until fracture, death, or
concentration was also estimated during the third loss to follow-up. The active treatment analysis in
year of the study in February and March in a ran cluded the participants as long as they stated that
dom sample of 96 participants drawn from the re they were using the trial medication. Thus, the par
maining study population. These participants re ticipants were included in the active treatment anal
ceived a letter giving them an appointment within ysis until they stopped using the trial medication,
10 days; the blood samples were drawn at home. regardless of whether a fracture occurred after they
Serum 25(OH)D concentration was measured by had stopped. Age, sex, and residence were added in
competitive protein binding assay after being puri both analyses as covariates to the Cox regression
fied by gradient high-pressure liquid chromatogra model. Because outdoor score, sunshine score, and
phy. The intra- and interassay coefficients of varia walking score were interrelated (correlation coeffi
tion were 5% and 6%, respectively (22). cients ranging from 0.21 to 0.59) and were likely to
indicate "general health" or "mobility," they were
Statistical Analysis averaged over the years and added up to a sum
Baseline data of the vitamin D group and the score. For this purpose, the walking score was sim
placebo group were compared using Mests (age, plified (1, 2, or 3 = 1; 4 = 2; 5 = 3), because the
calcium intake), chi-square tests (sex, residence), lower walking scores applied to a few participants
and Wilcoxon rank-sum tests (scores). The serum only. The resulting total score, ranging from 3 to 9,
25(OH)D concentrations of both groups were com was entered as a covariate in the model. The level
pared using /-tests. of compliance (weekly intake as reported on the
Data on fractures and mortality were analyzed by questionnaire) was also added as a covariate to the
survival analysis using log-rank tests, Cox propor active treatment analysis. Separate survival analyses
tional hazards regression, and hazard rate ratios were done for hip fractures and other peripheral
fractures. In the analysis for hip fractures, we used
the time to the first hip fracture, regardless of other
Table 1. Baseline Characteristics of Participants Randomly peripheral fractures. In the analysis for other pe
Assigned to Receive Placebo or Vitamin D* ripheral fractures, we used the time to the first
peripheral fracture, regardless of hip fractures. The
Characteristic Patients Patients
analyses were repeated after we excluded partici
Receiving Receiving
Placebo Vitamin D pants who used vitamin D or multivitamin supple
(n= 1287) (n= 1291)
ments other than the trial medication.
Mean age ± SD, y 80.0 ± 6.0 80.0 ± 5.9
Sex, n
Female 958 958
Male 329 333
Residence, n Results
Independent 528 519
Apartment for the elderly 253 252
Home for the elderly 506 520 Baseline data for the participants are presented
Outdoor score, ni
in Table 1. There were no important differences in
1 (outdoors < once per week) 152 153
2 (outdoors 1-2 times per week) 153 144 baseline characteristics between the groups. A study
3 (outdoors >3 times per week) 981 993
of nonparticipation in 267 potential participants
Sunshine score, ni
1 (in the shadow) 343 323 from one institution showed that 30 potential par
2 (sometimes in sunshine) 506 501
ticipants had had to be excluded on the basis of
3 (much sunshine exposure) 436 466
Walking score, ni exclusion criteria. Of the remaining 237 persons, 54
1 (unable to walk) 7 8
(23%) consented to participate. The mean ages of
2 (able to walk between two
persons) 24 17 the 54 participants (83.2 years) and the 183 nonpar-
3 (walks with mechanical aid
ticipants (83.0 years) did not differ, nor did the sex
[supervised]) 65 66
4 (walks a limited distance) 336 355 ratios of the two groups. The outdoor, sunshine,
5 (walks independently) 855 844
and walking scores tended to be lower in the non-
Median calcium intake, mg/dt
(25th-75th percentile) 859(644-1099) 876(638-1101) participants than in the participants. For example,
the walking score was lower than 4 in 11% of the
* There were no statistically significant differences between the group receiving placebo
and the group receiving vitamin D. participants and 17% of the nonparticipants. Rea
t Fewer than 0.5% missing values.
sons for not giving consent were primarily "infor-
$ Calcium intake from dairy products estimated in a subset of 348 women.
402 15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
Table 2. Mortality, Cessation of Treatment Loss to concentrations between the placebo group and the
Follow-up, and Active Treatment at 3 Years
vitamin D group was greater in institutionalized than
of Study
in independent elderly persons.
Variable Patients Receiving Patients Receiving P During the total follow-up period, 111 hip frac
Placebo Vitamin D Value tures occurred in 106 participants; 5 participants
n had a hip fracture on each side. There were 157
other peripheral fractures in 151 participants.
Death 251 223 0.16
Eleven participants sustained both a hip fracture
Cessation of treatment* 237 227 0.54
Active treatmentt 792 834 and another fracture. The fracture data are pre
Loss to follow-up 7 7
Total 1287 1291 sented in Table 4; the hip fracture data are shown
in Figure 1. The vitamin D group had slightly more
* Determined from participants' self-report on questionnaires, hip fractures than the placebo group, but the dif
t Determined from participants' self-report.
ference was not statistically significant. This is ap
parent in the Kaplan-Meier curve in the top panel
mation not received or forgotten," "other commit
of Figure 1. The unadjusted hazard rate ratio for
ments," "illness," and "no interest."
hip fractures (vitamin D compared with placebo)
At the start of the study, 133 participants were
according to the intention-to-treat analysis was 1.18
taking a vitamin or multivitamin preparation that
(95% CI, 0.81 to 1.71). When the residents of apart
usually contained 90 to 400 IU of vitamin D. During
ment houses and homes for elderly were analyzed
the study, 73 participants (37 in the placebo group
as a separate subgroup, 36 hip fractures occurred in
and 36 in the vitamin D group) were found to be
the placebo group, and 49 hip fractures occurred in
taking a vitamin or multivitamin supplement that
the vitamin D group (hazard rate ratio according to
contained vitamin D at two or more follow-up visits.
intention-to-treat analysis, 1.3 [CI, 0.84 to 2.0]).
Data on mortality, cessation of trial medication,
When participants 80 years of age and older were
loss to follow-up, and active treatment at 3 years
analyzed as a separate subgroup, the results were
after randomization are presented in Table 2. The
similar (hazard rate ratio, 1.13 [CI, 0.70 to 1.80]).
number of participants who died or stopped using
Including age, sex, residence, and sum score (out
the trial medication was higher (although not sig
door, sunshine, and walking scores) as covariates
nificantly higher) in the placebo group than in the
did not change the results. Excluding persons who
vitamin D group. It can be seen that 1626 partici
regularly used vitamin or multivitamin supplements
pants, or 63% of the 2578 participants at the start
did not change the results. The unadjusted hazard
of the study, completed 3 years of the study. After
rate ratio for other peripheral fractures (vitamin D
3 years, the 1313 participants who had started early
within the inclusion period were asked to continue, compared with placebo) was 1.03 (CI, 0.75 to 1.40).
and 1194 of these participants consented to enter Adjustment for covariates and the exclusion of per-
the 6-month extension period. This group was, on
average, 1 year younger than the remaining study
sample. The maximal follow-up period was 4 years
Table 3. Serum 25-Hydroxyvitamin D Concentrations in
(6 months after medication was stopped). The me Residents of Apartments or Homes for the
dian duration of follow-up was 3.5 years, and the Elderly at Baseline and after 1 Year of Treatment
and in Randomly Selected Participants in the
total follow-up time was 8450 patient-years. During
Third Year of the Study during Winter
the total follow-up period, 306 participants in the
placebo group and 282 participants in the vitamin D Variable Patients Patients P
Receiving Receiving Value
group died (P = 0.20 by survival analysis).
Placebo Vitamin D
Compliance was considered to be adequate if the
nmol/L (25th-75th
participants reported on the questionnaire that they percentile)
took the tablets 5 or more days per week. This
occurred in 85% of the participants; compliance was Residents of apartments and
homes for the elderly
similar in both groups. The serum 25(OH)D con (n = 270)*
centrations measured at baseline and after 1 year of Baseline 26(19-37) 27(19-36)
After 1 year 23(17-31) 62 (52-70) 0.001
treatment in a sample of 270 residents of apartment Random sample (n = 96) during
houses or homes for the elderly and those measured third year of study 23(17-28) 54(43-61) 0.001
Independent elderly persons
in 96 randomly selected participants in the third (n = 46) 26(18-35) 49(41-62)
year of our study are shown in Table 3. The overlap Residents of apartments and
homes for elderly persons
in the distribution of concentrations between partic (n = 50) 21 (15-26) 55 (45-60)
ipants receiving placebo and participants receiving
vitamin D was small. The contrast in serum 25(OH)D " Part of a substudy on the effect of vitamin D on bone mineral density and bone
turnover (21).
15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4 403
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
Table 4. Patients with Hip Fractures and Other Peripheral According to Cummings and coworkers (26), a de
Fractures in the Placebo and Vitamin D Group* crease of 1 standard deviation in bone mineral den
sity of the hip increases hip fracture risk by a factor
Fracture Patieni ts Receivi ng Patien ts Receiving3 PValuet
(risk ratio) of 2.6. When these data are combined, it
F'l acebo V'i tamin D
can be calculated that a 2.3% increase in bone
n
mineral density of the femoral neck might result in
Hip fracture 48 58 0.39 a decrease in hip fracture incidence of about 15%
Other fractures 74 77 0.86 and a risk ratio of 0.85 (27). We could have missed
Colles 22 20
Humerus 12 10 such a decrease because it is within the 95% CIs of
Ankle, foot, or leg 17 20 the observed hazard rate ratio. The power of our
Other 23 27
study was such that a decrease in the hip fracture
* Maximal follow-up was 4 years. incidence of 20% or more could have been shown.
t According to intention-to-treat analysis (log-rank test).
Our study may also have underestimated the ef
fect of vitamin D supplementation in other ways.
sons who regularly used vitamin or multivitamin The 248 participants who had repeated bone min
supplements did not change the results. eral density measurements were women living in
Data on the active treatment analysis, in which apartment houses and homes for the elderly. This
participants were included as long as they used the sample was not random and did not contain men or
trial medication, are shown in the bottom panel of elderly persons living independently. Vitamin D
Figure 1. This figure shows that the curves of the supplementation may have less effect in elderly per
placebo group and the vitamin D group are similar. sons living independently, because these persons are
The unadjusted hazard rate ratio for hip fractures younger and have higher serum 25(OH)D concen
(vitamin D compared with placebo) according to trations than residents of homes for the elderly. The
the active treatment analysis was 1.10 (CI, 0.71 to visible effect of vitamin D supplementation in our
1.70). For other peripheral fractures, it was 1.02 study may also have been decreased by the 73 par
(CI, 0.73 to 1.40). The inclusion of age, sex, resi ticipants who regularly used vitamin or multivitamin
dence, sum score, and compliance as covariates did supplements. However, excluding these participants
not change the results. did not change our results. We chose to include
these persons and to do the additional analysis be
cause it is difficult to completely eliminate the use
of vitamin supplements.
Discussion
The effect of vitamin D supplementation by in
Vitamin D supplementation did not decrease the tramuscular injection has been studied in Finland
incidence of hip fractures in our study population. (28). A decrease in the incidence of upper limb
The hypothesis of a protective effect of vitamin D fractures was found, in contrast to our results. How
had been based on previous studies done in the ever, the participants in the Finnish study were all
Netherlands (10, 24), which showed that vitamin D residents of nursing homes.
supplementation in elderly persons deficient in vita The effect of vitamin D, 800 IU/d, and calcium,
min D led to an adequate improvement of vitamin 1200 mg/d, compared with double placebo was stud
D status, as determined by significant increases of ied in 3270 elderly women in Lyon, France, by
the serum 25(OH)D and l,25(OH)2D concentra Chapuy and colleagues (29). These investigators ob
tions and a decrease of the serum parathyroid hor served a 25% decrease (intention-to-treat analysis)
mone concentration. In contrast, vitamin D supple in the incidence of hip fractures and other periph
mentation in nursing home residents in the United eral fractures. Important differences between our
States who were replete with vitamin D (mean se study conditions and those of Chapuy and col
rum 25(OH)D concentration > 40 nmol/L) did not leagues include a considerably lower dietary calcium
significantly decrease the parathyroid hormone con intake in France than in the Netherlands and the
centration (25). A positive effect of vitamin D was use of a calcium supplement in the French study.
also suggested by the results of the substudy done in The participants in the French study were an aver
248 women from the present study (13). This sub- age of 3 years older (at baseline) than our partici
study showed that bone mineral density in the hip pants, were all women, and were all residents of
at baseline correlated positively with the serum nursing homes.
25(OH)D concentration below a threshold level [se Hip fracture incidence was higher in the French
rum 25(OH)D < 30 nmol/L]. After 2 years of vita study than in our study. The incidence in our study
min D supplementation, the bone mineral density of was 25 per 1000 participants per year in women
the femoral neck had increased 2.3% in the vitamin living in homes for the elderly and 29 per 1000
D group compared with the placebo group (21). participants per year in women older than 85 years
404 15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
Figure 1. Cumulative proportion of participants with first hip fracture (Kaplan-Meier method) in the placebo group (X) and the group
assigned to receive vitamin D3 treatment (•). Top. According to intention-to-treat analysis. Bottom. According to active treatment analysis.
of age. In the French prevention study, the inci D supplementation (21). The difference in bone
dence was 40 per 1000 participants per year in mineral density of the hip between the treatment
women older than 85 years of age (29). The vitamin group and the control group was more than 6% in
D dosage in the French study was higher (800 IU/d) the French study and only 2.3% in a nonrandom
than in our study. However, as we have shown sample from our study (21). In sum, the changes in
previously (10), the difference between the effects of parathyroid activity and bone mineral density of the
400 and 800 IU of vitamin D per day is almost hip indicate that a larger treatment effect occurred
3
negligible. Serum 25(OH)D concentration in the in the French study.
French study was similar to that in ours, but the Participants in our study may have been more
measurement technique used by Chapuy and col active than the average, because the incidence of
leagues was different from the one we used. Cross- fractures in our study was lower than expected.
calibration of the assays suggests that the partici About 60% of the more than 60 homes for the
pants in the French study had greater vitamin D elderly in Amsterdam participated in our study, but
deficiencies than our participants (30). The decrease the percentage of persons in each home who par
in serum parathyroid hormone concentration in a ticipated varied from 5% to 30%. We gained the
sample of the French study was about 50% after impression that frailer elderly persons more often
calcium and vitamin D treatment (29), whereas this refrained from participation; this was also suggested
concentration decreased slightly more than 15% in by the results of our small nonparticipation study.
a nonrandom sample from our study after vitamin However, analysis of the older and less active sub-
15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4 405
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
group did not show a trend toward a protective 2. Lips P, Obrant KJ. The pathogenesis and treatment of hip fractures. Osteo
porosis Int. 1991;1:218-31.
effect of vitamin D supplementation.
3. Lips P, van Ginkel FC, Jongen MJ, Rubertus A, van der Vijgh WJ,
Our results do not show that vitamin D supple Netelenbos JC. Determinants of vitamin D status in patients with hip fracture
and in elderly control subjects. Am J Clin Nutr. 1987;46:1005-10.
mentation in elderly persons in the Netherlands de
4. Holick MF. Vitamin D and the skin: photobiology, physiology and therapeutic
creases the incidence of hip fractures and other efficacy for psoriasis. In: Heersche DN, Kanis JA, eds. Bone and Mineral Re
search. Amsterdam: Elsevier; 1990:313-66.
peripheral fractures. The data suggest that other 5. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon
risk factors are more important in our study popu GD. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982;36(5
Suppl): 1014-31.
lation. Nevertheless, a positive effect of vitamin D 6. Lips P. Vitamin D nutrition in the elderly: problems and recommendations. In:
Norman AW, Bouillon R, Thomasset M, eds. Vitamin D: Gene Regulation,
supplementation is suggested by the small increase
Structure-Function Analysis and Clinical Application. New York: Walter de
in bone mineral density of the femoral neck ob Gruyter; 1991:757-64.
7. Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in
served in a sample of this study (21). The effect of
the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol
vitamin D supplementation might be greater when a deficiency. Am J Clin Nutr. 1987;45:755-63.
8. Lips P, Hackeng WH, Jongen MJ, van Ginkel FC, Netelenbos JC. Sea
calcium supplement is also used, as in the French sonal variation in serum concentrations of parathyroid hormone in elderly
study (29). The same results might not be found in people. J Clin Endocrinol Metab. 1983;57:204-6.
9. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B.
the Netherlands, however, where dietary calcium Effect of vitamin D intake on seasonal variations in parathyroid hormone
intake is much higher than in France. A major secretion in postmenopausal women. N Engl J Med. 1989;321:1777-83.
10. Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hack
difference between our study and the two previous eng WH, et al. The effect of vitamin D supplementation on vitamin D status
and parathyroid function in elderly subjects. J Clin Endocrinol Metab. 1988;
studies in which vitamin D supplementation ap
67:644-50.
peared to be effective (28, 29) may be the health 11. Lips P, Netelenbos JC, Jongen MJ, van Ginkel FC, Althuis AL, van
Schaik CL, et al. Histomorphometric profile and vitamin D status in patients
status of the participants, which was generally better with femoral neck fracture. Metab Bone Dis Relat Res. 1982;4:85-93.
in our study. It may be that the effect of vitamin D 12. Khaw KT, Sneyd MJ, Compston J. Bone density, parathyroid hormone and
25-hydroxyvitamin D concentrations in middle aged women. BMJ. 1992;305:
supplementation on the incidence of fractures may 273-7.
only be apparent in an older, frailer population than 13. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Beze
mer PD, et al. Vitamin D status and sex hormone binding globulin: deter
ours. If so, vitamin D supplementation might there minants of bone turnover and bone mineral density in elderly women. J Bone
Miner Res. 1995;10:1177-84.
fore be considered primarily for frail elderly persons
14. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll U, Falconer G.
who do not go outdoors in the sunshine. Effect of vitamin D supplementation on wintertime and overall bone loss in
healthy postmenopausal women. Ann Intern Med. 1991;115:505-12.
15. Melton U 3d, Eddy DM, Johnston CC Jr. Screening for osteoporosis. Ann
Acknowledgments: The authors thank the many persons who con Intern Med. 1990;112:516-28.
tributed to this study, especially Mrs. Nel van der Kreeke, Els 16. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM,
Lommerse-Rusman, Saskia van Bennekom, Madeleine de Boer, et al. Effect of fluoride treatment on the fracture rate in postmenopausal
and Andries Tahapary for invaluable organizational help; Drs. women with osteoporosis. N Engl J Med. 1990;322:802-9.
Ronald ter Schegget, Didy Kriegsman, and Nico de Neeling for 17. Mosekilde L, Mosekilde L, Danielsen CC. Biomechanical competence of
vertebral trabecular bone in relation to ash density and age in normal indi
their help in the start-up phase of the study; Dr. Wim J. van der
viduals. Bone. 1987;8:79-85.
Vijgh and Simon Velt for the measurement of 25-hydroxyvitamin 18. Cummings SR, Nevitt MC. A hypothesis: the causes of hip fractures.
D; Hans Wagemaker for the randomization of the tablets; Dr. J Gerontol. 1989;44:107-11.
W. Ezechiels and other general practitioners for their help; staff 19. Kanis JA. Treatment of osteoporotic fracture. Lancet. 1984;1:27-33.
and personnel of the participating homes for the elderly for their 20. Lips P, van Ginkel FC, Netelenbos JC, Wiersinga A, van der Vijgh WJ.
assistance; and Drs. Olli Miettinen and Hans Valkenburg for Lower mobility and markers of bone resorption in the elderly. Bone Miner.
1990;9:49-57.
advice in designing the study.
21. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P.
Prevention of bone loss by vitamin D supplementation in elderly women: a
Grant Support: In part by the Praeventiefonds, the Hague, the randomized double-blind trial. J Clin Endocrinol Metab. 1995;80:1052-8.
Netherlands (grant 28-1112-1). Vitamin D and placebo tablets 22. Jongen MJ, Kuiper S, van der Vijgh WJ, Lips P, Netelenbos JC. Im
were provided by Solvay-Duphar, Inc., Weesp, the Netherlands. provement in the simultaneous determination of calcidiol and calcitriol in
human serum or plasma. J Clin Chem Clin Biochem. 1988;26:25-8.
23. Armitage P, Berry G. Statistical Methods in Medical Research. 2d ed. Bos
Requests for Reprints: Paul Lips, MD, Department of Endocrinol ton: Blackwell Scientific; 1987.
ogy, Academisch Ziekenhuis Vrije Universiteit, PO Box 7057, 24. Chapuy MC, Chapuy P, Meunier PJ. Calcium and vitamin D supplements:
1007 MB Amsterdam, the Netherlands. effects on calcium metabolism in elderly people. Am J Clin Nutr. 1987;46:
324-8.
25. Himmelstein S, Clemens TL, Rubin A, Lindsay R. Vitamin D supplemen
Current Author Addresses: Dr. Lips: Department of Endocrinol
tation in elderly nursing home residents increases 25(OH)D but not
ogy, Academisch Ziekenhuis Vrije Universiteit, PO Box 7057,
1,25(OH)2D. Am J Clin Nutr. 1990;52:701-6.
1007 MB Amsterdam, the Netherlands. 26. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K,
Mr. Graafmans and Drs. Ooms, Bezemer, and Bouter: Institute et al. Bone density at various sites for prediction of hip fractures. The Study
for Research in Extramural Medicine (EMGO Institute), Medi of Osteoporotic Fractures Research Group. Lancet. 1993;341:72-5.
cal Faculty, Vrije Universiteit, Van der Boechorststraat 7, 1081 27. Ooms ME. Osteoporosis in Elderly Women: Vitamin D Deficiency and Other
Risk Factors [PhD Thesis]. Amsterdam: Vrije Universiteit; 1994.
BT Amsterdam, the Netherlands.
28. Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH,
Kataja JM, et al. Annual injection of vitamin D and fractures of aged bones.
Calcif Tissue Int. 1992;51:105-10.
29. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al.
References Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl
J Med. 1992;327:1637-42.
30. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA. International compari
1. McKenna MJ. Differences in vitamin D status between countries in young son of serum 25-hydroxyvitamin D measurements [Abstract]. J Bone Miner
adults and the elderly. Am J Med. 1992;93:69-77. Res. 1995;10:S496.
406 15 February 1996 • Annals of Internal Medicine • Volume 124 • Number 4
Downloaded From: http://annals.org/ by a La Trobe University User on 12/11/2016
